dc.contributor.author | Cakmak, H. A. | |
dc.contributor.author | Ikitimur, Barış | |
dc.contributor.author | Yuksel, H. | |
dc.contributor.author | Ekmekci, H. | |
dc.contributor.author | Tufekcioglu, E. Y. | |
dc.contributor.author | Aslan, S. | |
dc.contributor.author | Karadag, B. | |
dc.date.accessioned | 2021-03-05T18:09:50Z | |
dc.date.available | 2021-03-05T18:09:50Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Aslan S., Ikitimur B., Cakmak H. A. , Karadag B., Tufekcioglu E. Y. , Ekmekci H., Yuksel H., "Prognostic utility of serum vitronectin levels in acute myocardial infarction", HERZ, cilt.40, ss.685-689, 2015 | |
dc.identifier.issn | 0340-9937 | |
dc.identifier.other | av_c9077e18-3b89-4eda-9c0f-42d221479f7a | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/133219 | |
dc.identifier.uri | https://doi.org/10.1007/s00059-014-4105-2 | |
dc.description.abstract | Background. Vitronectin (VN) functions as a regulator of platelet adhesion and aggregation, coagulation, and fibrinolysis. The aim of this study was to assess the prognostic significance of serum VN levels in patients with acute myocardial infarction (MI). | |
dc.language.iso | eng | |
dc.subject | Kardiyoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | CARDIAC ve CARDIOVASCULAR SİSTEMLER | |
dc.title | Prognostic utility of serum vitronectin levels in acute myocardial infarction | |
dc.type | Makale | |
dc.relation.journal | HERZ | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 40 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 685 | |
dc.identifier.endpage | 689 | |
dc.contributor.firstauthorID | 89667 | |